13 patient data entries in database for clusters A467T and W748S in age group "juvenile". Entry # | Mutations | allele 1 | allele 2 |
| Clinical representation | Symptoms | Age group | Age of onset | Age of patient | Age of death | Reference | | 90 | W748S5
| A467T2
| MELAS-like, features including occipital lobe epilepsy. | | | n/a | 19 | n/a | Blok et al, 2009; [view data] | 125 | W748S5
| A467T2
| Autistic features, headaches/migraines, ataxia, seizures, intractable seizure, optic atrophy, abnormal MRI, dystonia, posterior stroke, abnormal EEG. 101% mtDNA copy number in blood. | - | movement disorder (ataxia) | |
| | n/a | 18 | n/a | Tang et al, 2011; [view data] | 342 | A467T2
| W748S5
| Ataxia, dysarthria, suffered two generalized seizures, and developed severe progressive cognitive decline and psychiatric manifestations including visual and auditory hallucinations, bilateral external ophthalmoplegia, bilateral ptosis, and reduced visual acuities, bilateral sensorineural hearing loss, proximal muscle weakness in all four limbs and was areflexic, severe sensory neuropathy and myopathy, | - | movement disorder (ataxia) | |
- | external ophthalmoplegia | |
| | n/a | 18 | 65 | Kinghorn et al, 2012; [view data] | 363 | W748S5
| A467T2
| Peripheral neuropathy, ataxia, epilepsy, COX-deficient fibers, presence of mitochondrial dna deletions in muscle, Moderate sensory neuronopathy | - | movement disorder (ataxia) | |
| | 16 | 18 | n/a | Lax et al, 2012a; [view data] | 386 | W748S5 E1143G
| A467T2
| Presented with epilepsy and headaches, ataxia, status epilepticus, nystagmus, myoclonus, neuropathy. Sodium valproate treatment 6 weeks prior to death. Liver dysfunction, cause of death status epilepticus and liver failure. Hepatic histology showed acute liver necrosis. | - | movement disorder (ataxia) | |
| | 19 | n/a | 19 | Tzoulis et al, 2006; [view data] | 388 | W748S5 E1143G
| A467T2
| Presented with epilepsy, status epilepticus, headaches, nystagmus, myoclonus, neuropathy. Sodium valproate treatment 7 weeks prior to death. Liver dysfunction and rising liver enzymes and bilirubin terminally, cause of death status epilepticus. Hepatic histology showed centrolobular degeneration. | | | 15 | n/a | 21 | Tzoulis et al, 2006; [view data] | 389 | W748S5 E1143G
| A467T2
| Presented with epilepsy and headaches, ataxia, epilepsy, status epilepticus, myoclonus, neuropathy. Sodium valproate treatment 7 weeks prior to death. Liver dysfunction and rising liver enzymes and bilirubin terminally, cause of death status epilepticus. Hepatic histology showed centrolobular degeneration. | - | movement disorder (ataxia) | |
| | 14 | n/a | 23 | Tzoulis et al, 2006; [view data] | 439 | W748S5
| A467T2
| R-EPC (refractory epilepsia partialis continua), axonal neuropathy, cerebellar ataxia, hyperintensity of rolandic, occipital and cerebellar cortex and dentate nucleus. | - | movement disorder (ataxia) | |
- | demyelinating neuropathy | |
| | 17 | n/a | n/a | Rouzier et al, 2013; [view data] | 456 | W748S5
| A467T2
| Focal parieto-occipital lobe seizures, migraine headaches, cerebellar ataxia, sensory–motor axonal neuropathy, and impairment of visual perception and cognitive function. | - | movement disorder (ataxia) | |
- | demyelinating neuropathy | |
| | 15 | 16 | n/a | Roshal et al, 2011; [view data] | 555 | W748S5
| A467T2
| Epilepsy, stroke-like episode, Ataxia, Neuropathy. | - | movement disorder (ataxia) | |
| | 14 | n/a | 23 | Tzoulis et al, 2014; [view data] | 556 | W748S5
| A467T2
| Epilepsy, stroke-like episode, Ataxia, Neuropathy. | - | movement disorder (ataxia) | |
| | 13 | n/a | 21 | Tzoulis et al, 2014; [view data] | 674 | W748S5 E1143G
| A467T2
| Migraine, ataxia, polyneuropathy. focal seizures with visual symptoms and motor signs, and secondary generalized tonic-clonic seizure. Clinical neurological examination revealed an ataxic gait and areflexia with sensory loss. Convulsive status epilepticus. Cerebral MRI revealed a left occipital and left thalamic lesion. | - | movement disorder (ataxia) | |
| | 17 | 20 | 23 | Janssen et al, 2016; [view data] | 677 | W748S5 E1143G
| A467T2
| Presented with status epilepticus, occipital lobe seizures. Further neurologic examination showed ataxic gait and appendicular ataxia. chronic sensory axonal polyneuropathy. Cognitive decline. At follow-up consultation 6 months after the initial presentation, she had not experienced any more seizures. | - | movement disorder (ataxia) | |
- | axonal sensorimotor polyneuropathy | |
| | 18 | 18.7 | n/a | Janssen et al, 2016; [view data] |
1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details. Number of displayed patient cases: 13 Avg age of onset in displayed cases: 16.4 Std dev in onset in displayed cases: 1.9
|